Bone Forming at Prosthetic Surfaces. Fingerprint2
1 other identifier
interventional
26
1 country
1
Brief Summary
What is the intensity of F-PET uptake in healthy and osteo arthritic femur and acetabulum, compared to the uptake adjacent to four analyzed endoprosthetic components 1½ and 6 months after surgery?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Aug 2011
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 17, 2012
CompletedFirst Posted
Study publicly available on registry
June 20, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedApril 4, 2014
April 1, 2014
3.1 years
January 17, 2012
April 3, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
FEMUR: to analyze difference in SUV of the 4 upper ROI's (No 1, 7, 8 and 13) analyzed together between the cemented and uncemented groups AND: to analyze SUV of the 4 upper ROI's analyzed together between each femur study group and the reference group
There are two study groups for femur: cemented and uncemented femur prosthetic components. There are also a femur reference group.
6 weeks after surgery
ACETABULUM: to analyze difference in SUV of all 9 ROI's analyzed together between the cemented and uncemented acetabular study groups, and to analyze SUV of all 9 ROI's analyzed together between each acetabulum study group and the reference group
There are two study groups for acetabulum: cemented and uncemented acetabular prosthetic components. There are also an acetabular reference group.
6 weeks after surgery
Secondary Outcomes (10)
FEMUR:to analyze difference in SUV for each individual ROI inbetween the cemented and uncemented femur group
6 weeks and 6 months
FEMUR: to analyze difference in SUV for each individual ROI between the cemented study group and the reference group. To analyze difference in SUV for each individual ROI between the uncemented study group and the reference group.
6 weks and 6 months
FEMUR:to analyze difference in SUV for each individual ROI between the 3 time points for the cemented group. To analyze difference in SUV for each individual ROI between the 3 time points for the uncemented group.
preoperatively, 6 weeks and 6 months
FEMUR:to analyze difference in SUV for the 4 upper ROI's (No 1, 7, 8 and 13)analyzed together between the 2 study groups
6 months
FEMUR:to analyze difference in SUV for the 4 upper ROI's analyzed together between each study group and the reference group
6 months
- +5 more secondary outcomes
Study Arms (4)
Regenerex
ACTIVE COMPARATORLub cup
ACTIVE COMPARATORSP II
ACTIVE COMPARATORCorail
ACTIVE COMPARATORInterventions
A fibrous metal uncemented Regenerex RingLoc cup (Biomet, Warsaw, Il, USA)
cemented Lubinus cross linked cup (Waldemar Link, Hamburg, Germany).
Cemented Lubinus SP II stem (Waldemar Link, Hamburg, Germany) with a ceramic 32 mm head.
Uncemented HA-coated Corail stem with a ceramic 32 mm head (DePuy, Johnsson \& Johnsson, USA).
Eligibility Criteria
You may qualify if:
- patients diagnosed to have unilateral hip osteo arthritis (Charnley group A) aimed for THA at the orthopedic clinic Gävle hospital.
You may not qualify if:
- Systemic disease or medication affecting the skeleton
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre for research and development Uppsala university/County council of Gävleborg
Gävle, 80187, Sweden
Related Publications (2)
Ullmark G, Sorensen J, Nilsson O, Maripuu E. Bone mineralisation adjacent to cemented and uncemented acetabular cups: analysis by [18F]-fluoride-PET in a randomised clinical trial. Hip Int. 2020 Nov;30(6):745-751. doi: 10.1177/1120700019861274. Epub 2020 Jul 19.
PMID: 32686502DERIVEDUllmark G, Sorensen J, Maripuu E, Nilsson O. Fingerprint pattern of bone mineralisation on cemented and uncemented femoral stems: analysis by [18F]-fluoride-PET in a randomised clinical trial. Hip Int. 2019 Nov;29(6):609-617. doi: 10.1177/1120700018815404. Epub 2018 Dec 6.
PMID: 30520317DERIVED
Study Officials
- STUDY CHAIR
Gösta Ullmark
Ass Professor
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2012
First Posted
June 20, 2012
Study Start
August 1, 2011
Primary Completion
September 1, 2014
Study Completion
March 1, 2015
Last Updated
April 4, 2014
Record last verified: 2014-04